Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Incannex Healthcare (IXHL) Shares Outstanding (2022 - 2025)

Incannex Healthcare's Shares Outstanding history spans 3 years, with the latest figure at $359.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 1919.76% to $359.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $359.2 million, a 1919.76% increase, with the full-year FY2025 number at $194.4 million, up 1001.75% from a year prior.
  • Shares Outstanding hit $359.2 million in Q4 2025 for Incannex Healthcare, up from $347.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding for IXHL hit a ceiling of $359.2 million in Q4 2025 and a floor of $15.9 million in Q2 2023.
  • Historically, Shares Outstanding has averaged $95.0 million across 3 years, with a median of $17.6 million in 2024.
  • Biggest five-year swings in Shares Outstanding: grew 11.15% in 2024 and later skyrocketed 1919.76% in 2025.
  • Tracing IXHL's Shares Outstanding over 3 years: stood at $15.9 million in 2023, then rose by 12.05% to $17.8 million in 2024, then skyrocketed by 1919.76% to $359.2 million in 2025.
  • Business Quant data shows Shares Outstanding for IXHL at $359.2 million in Q4 2025, $347.7 million in Q3 2025, and $194.4 million in Q2 2025.